115 related articles for article (PubMed ID: 38215963)
1. CCR5 regulates Aβ
Huang HY; Salinas S; Cornell J; Udoh IB; Shen Y; Zhou M
Neurobiol Learn Mem; 2024 Feb; 208():107890. PubMed ID: 38215963
[TBL] [Abstract][Full Text] [Related]
2. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
[TBL] [Abstract][Full Text] [Related]
3. Systematic characterization of a non-transgenic Aβ
Jiménez-Herrera R; Contreras A; Djebari S; Mulero-Franco J; Iborra-Lázaro G; Jeremic D; Navarro-López J; Jiménez-Díaz L
Biol Sex Differ; 2023 Sep; 14(1):59. PubMed ID: 37716988
[TBL] [Abstract][Full Text] [Related]
4. Treadmill Exercise Ameliorates Spatial Learning and Memory Deficits Through Improving the Clearance of Peripheral and Central Amyloid-Beta Levels.
Khodadadi D; Gharakhanlou R; Naghdi N; Salimi M; Azimi M; Shahed A; Heysieattalab S
Neurochem Res; 2018 Aug; 43(8):1561-1574. PubMed ID: 29948724
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer's disease via activation of α7nAChR.
Chang KW; Zong HF; Rizvi MY; Ma KG; Zhai W; Wang M; Yang WN; Ji SF; Qian YH
Neurobiol Learn Mem; 2020 Feb; 168():107154. PubMed ID: 31904546
[TBL] [Abstract][Full Text] [Related]
6. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
7. Conditional knockout of AIM2 in microglia ameliorates synaptic plasticity and spatial memory deficits in a mouse model of Alzheimer's disease.
Ye L; Hu M; Mao R; Tan Y; Sun M; Jia J; Xu S; Liu Y; Zhu X; Xu Y; Bai F; Shu S
CNS Neurosci Ther; 2024 Jun; 30(6):e14555. PubMed ID: 38105588
[TBL] [Abstract][Full Text] [Related]
8. Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ
Xiang X; Wang X; Jin S; Hu J; Wu Y; Li Y; Wu X
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110423. PubMed ID: 34363866
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ
Jin S; Wang X; Xiang X; Wu Y; Hu J; Li Y; Lin Dong Y; Tan Y; Wu X
Int Immunopharmacol; 2021 Dec; 101(Pt B):108335. PubMed ID: 34781121
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of INT-777 against Aβ
Wu X; Lv YG; Du YF; Chen F; Reed MN; Hu M; Suppiramaniam V; Tang SS; Hong H
Brain Behav Immun; 2018 Oct; 73():533-545. PubMed ID: 29935310
[TBL] [Abstract][Full Text] [Related]
11. Chemerin-9 Peptide Enhances Memory and Ameliorates Aβ
Lei Z; Lu Y; Bai X; Jiang Z; Yu Q
Biol Pharm Bull; 2020 Feb; 43(2):272-283. PubMed ID: 31748466
[TBL] [Abstract][Full Text] [Related]
12. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
13. Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
Lang W; Li X; Wang Y; Duan Y; Wang Y; Wei P; Li X; Zhu Q; Cui Y
Neurosci Lett; 2022 Nov; 791():136887. PubMed ID: 36174844
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K
Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157
[TBL] [Abstract][Full Text] [Related]
15. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
[TBL] [Abstract][Full Text] [Related]
16. Insight into the roles of CCR5 in learning and memory in normal and disordered states.
Necula D; Riviere-Cazaux C; Shen Y; Zhou M
Brain Behav Immun; 2021 Feb; 92():1-9. PubMed ID: 33276089
[TBL] [Abstract][Full Text] [Related]
17. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42.
Zhang L; Fang Y; Lian Y; Chen Y; Wu T; Zheng Y; Zong H; Sun L; Zhang R; Wang Z; Xu Y
PLoS One; 2015; 10(4):e0122415. PubMed ID: 25849905
[TBL] [Abstract][Full Text] [Related]
19. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
20. Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats.
Zhang J; Wei SY; Yuan L; Kong LL; Zhang SX; Wang ZJ; Wu MN; Qi JS
Physiol Behav; 2017 May; 174():67-73. PubMed ID: 28257938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
